Published
July 5, 2026
If you bought Nara Organics infant formula before its June 2026 recall, this lawsuit could affect you — though there is no settlement or lawsuit claim form yet.
Allegations Only · No Settlement Yet
This article describes a class action complaint. The statements below are unproven allegations. Nara Organics, Inc. has not been found liable, there is no certified class, and there is nothing to claim at this time. Nara has publicly stated that none of its infant formula tested positive for Clostridium botulinum and that its recall was precautionary. This page is informational and is not legal or medical advice.
What Is This Lawsuit About?
Nara Organics, Inc. is facing a proposed class action alleging that it sold infant formula without disclosing on the packaging that the product could contain Clostridium botulinum, the bacterium associated with infant botulism. The complaint alleges consumers would not have bought the formula — or would not have paid as much for it — had that risk been disclosed. The case is captioned Zetterstrom v. Nara Organics, Inc., No. 1:26-cv-05026-JMF, and is pending in the U.S. District Court for the Southern District of New York. These are allegations only; Nara has not yet responded in court, and nothing has been proven.The backdrop is a product recall. On June 12, 2026, Nara issued a voluntary nationwide recall of its infant formula after the U.S. Food and Drug Administration shared information about several reported infant botulism cases in babies who, according to the CDC, had consumed Nara formula. Nara has publicly stated that, as of its recall notice, none of its formula had tested positive for C. botulinum, and that it issued the recall out of caution while working with the FDA, CDC, and state health departments. You can read the details on our Nara Organics infant formula recall page.
This lawsuit is a separate, consumer-focused matter. Rather than a personal-injury claim, it is an economic case: the complaint alleges the formula's labeling omitted a material safety risk, so purchasers lost the benefit of their bargain or paid a premium for a product they say they would not have bought. The complaint also alleges — as an unproven assertion by the plaintiff — that Nara's own recall and testing showed the presence of C. botulinum in the product the plaintiff purchased. That assertion is disputed by Nara's public statement that no formula tested positive, and it has not been established in court.
Status
Complaint Filed · June 14, 2026
Proposed class action · Zetterstrom v. Nara Organics, Inc. · S.D.N.Y.
What's Alleged
Packaging omitted a botulism (Clostridium botulinum) risk
An omission / benefit-of-the-bargain theory; the complaint also calls the recall inadequate
Recall
All Nara infant formula recalled June 12, 2026
Nara says no formula tested positive; recall issued as a precaution
Can I Claim?
No — nothing to claim from the lawsuit yet
No settlement, no class certified, and no lawsuit claim form at this stage
The Omission Theory
The core of the complaint is what the packaging did not say. According to the complaint, infant formula packaging is the one place every parent looks before buying, and a reasonable consumer reading Nara's labels would believe the formula is safe to feed an infant and free of harmful bacteria. The complaint alleges Nara did not list or warn about C. botulinum anywhere on the packaging, and that this omission was material because parents would not knowingly buy formula that carried a botulism risk.The complaint alleges Nara was in a superior position to know the risks in its manufacturing process and to test for contamination before releasing the formula, while consumers had no practical way to detect it at the point of sale — short of sending the product to a laboratory. On that basis, the plaintiff alleges Nara had a duty to disclose the risk and did not. Nara has not answered these allegations in court, and they remain unproven.
Why the Complaint Says the Recall Wasn't Enough
A significant part of the complaint targets the recall itself. The plaintiff alleges that to get a refund, a consumer generally has to still have the product — but a parent who learns their infant formula may carry a botulism risk is likely to throw it away immediately. The complaint also notes that many shoppers do not keep receipts and may buy formula at different stores. For those reasons, the complaint argues the recall was structured so that relatively few purchasers could actually obtain a refund, and that a class action is a superior way to reach everyone who bought the formula.This is the plaintiff's characterization of the recall, not a court finding. Recalls and consumer class actions serve different purposes, and a company running a precautionary recall is not, by itself, an admission of any of the complaint's allegations.
Read the Complaint
The full class action complaint in Zetterstrom v. Nara Organics, Inc. is embedded below. The reading copy has been reformatted for the web from the publicly filed document; exhibit images and personal identifiers from the original filing have been omitted.Who Is Covered and What the Lawsuit Seeks
The complaint proposes a nationwide class of everyone in the United States who purchased the products during the class period, along with a New York subclass and a California subclass. No class has been certified, so the final class definition and time period are not settled.The complaint brings five claims: deceptive acts and practices under New York General Business Law § 349; false advertising under New York General Business Law § 350; negligence; unjust enrichment; and unfair competition under California's Unfair Competition Law (Business & Professions Code § 17200). It seeks class certification, an injunction, actual and statutory damages (including the per-transaction statutory damages available under the New York statutes), treble and punitive damages, restitution, interest, and attorneys' fees. As with any newly filed complaint, those are requests, not awards — no money has been ordered and none is available now.
What Parents Should Know Right Now
This lawsuit does not create anything for consumers to file, and it is not a source of safety guidance. For product-safety steps, follow the official recall: Nara has urged parents to stop using all Nara Organics infant formula covered by the June 12, 2026 recall, and health authorities advise anyone whose infant shows symptoms such as poor feeding, weak cry, drooping eyelids, or difficulty breathing to seek medical care promptly. Our Nara Organics recall page has the affected sizes and lot information, and the FDA and CDC publish the latest guidance. This page is informational and is not medical advice.What Happens Next?
The case is at its earliest stage. No class has been certified, meaning the court has not decided whether the case can proceed on behalf of all purchasers. Nara will have an opportunity to answer the complaint and may move to dismiss or narrow the claims — food-labeling and omission cases are frequently contested on whether a reasonable consumer would be misled, whether the plaintiff suffered an economic injury, and whether federal food-labeling law preempts the state claims. If the case survives, the parties would exchange evidence in discovery before any class-certification decision. Many proposed consumer class actions are dismissed, narrowed, or settled before any payout, and there is no guarantee this case results in a settlement or recovery.This case fits a broader wave of food-safety and labeling lawsuits, alongside actions like the Chobani "20G Protein" yogurt lawsuit and the long-running Enfamil and Similac (NEC) infant-formula litigation. OpenClassActions.com will continue watching the docket for any major updates, including a motion to dismiss, class-certification activity, or a future settlement.
Do I Need to Do Anything Right Now?
No. There is no lawsuit claim form, no deadline, and no settlement fund at this stage. If the case ever advances to a settlement or judgment, class members would be notified about how to participate. For the recall refund process, follow Nara's official recall instructions rather than any third party that contacts you.Frequently Asked Questions
Is there a Nara Organics settlement or claim form?No. This is a newly filed complaint, not a settlement. There is no lawsuit claim form and no guarantee that consumers will ever receive money from this case. The June 12, 2026 recall is a separate process run by the company.
What does the lawsuit allege?
That Nara Organics sold infant formula without disclosing on its packaging that the product could contain Clostridium botulinum, and that the recall was structured so few purchasers could get a refund. The plaintiff alleges consumers overpaid or would not have bought the formula had the risk been disclosed. The allegations are unproven.
Didn't Nara say the formula tested negative?
Yes. Nara has publicly stated that none of its infant formula tested positive for C. botulinum and that it issued the recall as a precaution after the FDA and CDC reported illnesses. The complaint's assertion that testing showed contamination is the plaintiff's allegation and is disputed; it has not been established in court.
Who filed it and where?
A California consumer filed Zetterstrom v. Nara Organics, Inc., No. 1:26-cv-05026-JMF, on June 14, 2026 in the U.S. District Court for the Southern District of New York.
Sources
• Class Action Complaint, Zetterstrom v. Nara Organics, Inc., No. 1:26-cv-05026-JMF (S.D.N.Y. filed June 14, 2026) — complaint PDF• OpenClassActions.com — Nara Organics Infant Formula Recall (Botulism Risk)
• U.S. Food & Drug Administration — Recalls, Market Withdrawals & Safety Alerts: FDA.gov
• U.S. Centers for Disease Control and Prevention — infant botulism information: CDC.gov
About This Page
This page summarizes the class action complaint in Zetterstrom v. Nara Organics, Inc., No. 1:26-cv-05026-JMF (S.D.N.Y.). OpenClassActions.com is a consumer news site and is not a law firm, the plaintiff's counsel, Nara Organics, or a party to this case. The allegations in the complaint have not been proven in court, and Nara has publicly disputed that its formula tested positive for contamination. This page is for informational purposes only and does not constitute legal or medical advice.Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
For more class actions keep scrolling below.
Status
Complaint Filed — No Settlement, No Claim Form
Case Title
Zetterstrom v. Nara Organics, Inc.
Case Number
1:26-cv-05026-JMF
Court
U.S. District Court, Southern District of New York
Date Filed
June 14, 2026
Defendant
Nara Organics, Inc.
Claims
NY GBL §§ 349 & 350; negligence; unjust enrichment; California UCL § 17200
Class Status
Not yet certified — early stage
Complaint
Read the Complaint (PDF)
